Skip to main content Skip to navigation
PE Rat anti-Smad1 (pS463/pS465)/Smad8 (pS465/pS467)
PE Rat anti-Smad1 (pS463/pS465)/Smad8 (pS465/pS467)

Analyses of Smad1 (pS463/pS465)/Smad8 (pS465/pS467) expression by human peripheral blood mononuclear cells (PBMC).

     Multicolor flow cytometric analysis of Smad1 (pS463/pS465)/Smad8 (pS465/pS467) expressed by PBMC. Cells were cultured overnight in media containing 0.1% FBS and were then either not treated (dashed line histogram) or treated with Bone Morphogenetic Protein 6 (BMP-6; R&D Systems, Cat. No. 507-BP; 500 ng/ml, 15 min, 37°C; solid line histogram). Cells were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655; 10 min, 37˚C; Left Panel) or 1X BD Phosflow™ Lyse/Fix Buffer (Cat. No. 558049; 10 min, 37˚C; Middle Panel) and permeabilized in BD Phosflow™ Perm Buffer III (Cat. No. 558050; 30 min, on ice). Cells were then stained with BD Phosflow™ PE Rat anti-Smad1 (pS463/pS465)/Smad8 (pS465/pS467) (Cat. No. 562509) and Alexa Fluor® 647 Mouse Anti-Human CD20 (Cat. No. 558054) mAbs. Fluorescence histograms showing Smad1 (pS463/pS465)/Smad8 (pS465/pS467) expression were generated for CD20-positive gated events with the forward and side-light scatter characteristics of intact cells using a BD FACSCanto™ II Flow Cytometer System.

     Western blot analysis of Smad1 (pS463/pS465)/Smad8 (pS465/pS467) expression by human PBMC. Lysates were prepared from 1 million PBMC that were cultured overnight in media containing 0.1% FBS and were then either not treated (C) or treated (T) with BMP-6 (500 ng/ml, 15 min, 37°C). The lysates were electrophoresed, transferred to a membrane and blotted using Purified Rat anti-Smad1 (pS463/pS465)/Smad8 (pS465/pS467) mAb (Cat. No. 562508; 0.125 µg/ml for Lanes 1 and 2), HRP Goat Anti-Rat Ig (Cat. No. 554017) and a chemiluminescent detection system. Smad1 (pS463/pS465)/Smad8 (pS465/pS467) were identified as ~60 kDa bands by Westren blotting (Right Panel).

     Note: For all analyses shown, PBMC were isolated from freshly drawn EDTA blood.

Analyses of Smad1 (pS463/pS465)/Smad8 (pS465/pS467) expression by human peripheral blood mononuclear cells (PBMC).

     Multicolor flow cytometric analysis of Smad1 (pS463/pS465)/Smad8 (pS465/pS467) expressed by PBMC. Cells were cultured overnight in media containing 0.1% FBS and were then either not treated (dashed line histogram) or treated with Bone Morphogenetic Protein 6 (BMP-6; R&D Systems, Cat. No. 507-BP; 500 ng/ml, 15 min, 37°C; solid line histogram). Cells were fixed in BD Cytofix™ Fixation Buffer (Cat. No. 554655; 10 min, 37˚C; Left Panel) or 1X BD Phosflow™ Lyse/Fix Buffer (Cat. No. 558049; 10 min, 37˚C; Middle Panel) and permeabilized in BD Phosflow™ Perm Buffer III (Cat. No. 558050; 30 min, on ice). Cells were then stained with BD Phosflow™ PE Rat anti-Smad1 (pS463/pS465)/Smad8 (pS465/pS467) (Cat. No. 562509) and Alexa Fluor® 647 Mouse Anti-Human CD20 (Cat. No. 558054) mAbs. Fluorescence histograms showing Smad1 (pS463/pS465)/Smad8 (pS465/pS467) expression were generated for CD20-positive gated events with the forward and side-light scatter characteristics of intact cells using a BD FACSCanto™ II Flow Cytometer System.

     Western blot analysis of Smad1 (pS463/pS465)/Smad8 (pS465/pS467) expression by human PBMC. Lysates were prepared from 1 million PBMC that were cultured overnight in media containing 0.1% FBS and were then either not treated (C) or treated (T) with BMP-6 (500 ng/ml, 15 min, 37°C). The lysates were electrophoresed, transferred to a membrane and blotted using Purified Rat anti-Smad1 (pS463/pS465)/Smad8 (pS465/pS467) mAb (Cat. No. 562508; 0.125 µg/ml for Lanes 1 and 2), HRP Goat Anti-Rat Ig (Cat. No. 554017) and a chemiluminescent detection system. Smad1 (pS463/pS465)/Smad8 (pS465/pS467) were identified as ~60 kDa bands by Westren blotting (Right Panel).

     Note: For all analyses shown, PBMC were isolated from freshly drawn EDTA blood.

商品详情
Down Arrow Up Arrow


BD Phosflow™
Smad1,Smad8/Smad9; MADH1, MADH9
Human (QC Testing), Mouse (Predicted)
Rat IgG2a, κ
Phosphorylated Human Smad1 aa 456-465 Peptide
Intracellular staining (flow cytometry) (Routinely Tested)
~60 kDa
5 µl
AB_11154602
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
RUO


准备和存储

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The antibody was conjugated with R-PE under optimum conditions, and unconjugated antibody and free PE were removed. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

推荐的实验流程

In human PBMC, overnight serum starvation was found to be necessary for detection of a BMP-6-induced increase in Smad1/8 phosphorylation. Serum starvation for 1 hour following PBMC isolation was not sufficient to reduce basal levels of Smad1 (pS463/pS465)/Smad8(pS465/pS467).  Some donor variation was observed in the reduction of basal phosphorylation by overnight serum starvation.

商品通知

  1. This reagent has been pre-diluted for use at the recommended Volume per Test. We typically use 1 × 10^6 cells in a 100-µl experimental sample (a test).
  2. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
  3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
  5. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
562509 Rev. 1
抗体详情
Down Arrow Up Arrow
N6-1233

The N6-1233 monoclonal antibody specifically binds to the Smad1 protein phosphorylated at the Ser463/465 sites and the Smad8 protein phosphorylated at the Ser465/467 sites. Smad1 and Smad8 are ~60 kDa proteins and are members of the Smad superfamily. The Smad family members are divided into three subfamilies: receptor regulated Smads or R-Smads, including Smads1, 2, 3, 5, and 8; common partner Smad, or Co-Smad, including Smad4; and inhibitory Smads, or I-Smad, including Smads 6 and 7. Activation of Transforming Growth Factor-beta (TGF-beta) superfamily serine/threonine kinase receptors, such as TGF-beta and Bone Morphogenic  Protein (BMP) receptors, leads to the phosphorylation of R-Smads at several sites. It has been shown that Ser463 and Ser465 of Smad1 are phosphorylated by BMP receptors. In B cells and pre-B cells, BMP-6 has been shown to induce Smad1/5/8 phosphorylation and inhibit cell proliferation. Phosphorylated R-Smads form complexes with Co-Smad and translocate into the nucleus to regulate transcription affecting a wide range of critical processes including cell-fate determination, proliferation, morphogenesis, differentiation and apoptosis. The inhibitory Smads inhibit this pathway through two potential mechanisms: either by preventing R-Smads from binding to their corresponding receptors and/or by competing with Smad4, the Co-Smad, from binding to R-Smads. This antibody may crossreact with Smad5 pS463/pS465 based on sequence homology.

562509 Rev. 1
格式详情
Down Arrow Up Arrow
PE
R-Phycoerythrin (PE), is part of the BD family of Phycobiliprotein dyes. This fluorochrome is a multimeric fluorescent phycobiliprotein with excitation maximum (Ex Max) of 496 nm and 566 nm and an emission maximum (Em Max) at 576 nm. PE is designed to be excited by the Blue (488 nm), Green (532 nm) and Yellow-Green (561 nm) lasers and detected using an optical filter centered near 575 nm (e.g., a 575/26-nm bandpass filter). As PE is excited by multiple lasers, this can result in cross-laser excitation and fluorescence spillover on instruments with various combinations of Blue, Green, and Yellow-Green lasers. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.
altImg
PE
Yellow-Green 488 nm, 532 nm, 561 nm
496 nm, 566 nm
576 nm
562509 Rev.1
报价单和参考
Down Arrow Up Arrow

研发参考 (8)

  1. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996; 10(13):1580-1594. (Biology). 查看参考
  2. Hoodless PA, Haerry T, Abdollah S, et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell. 1996; 85(4):489-500. (Biology). 查看参考
  3. Kersten C, Dosen G, Myklebust JH, et al. BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3. Exp Hematol. 2006; 34(1):72-81. (Biology). 查看参考
  4. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH. BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1. BMC Immunol. 2005; 6:9. (Biology). 查看参考
  5. Kretzschmar M, Doody J, Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature. 1997; 389(6651):618-622. (Biology). 查看参考
  6. Kretzschmar M, Liu F, Hata A, Doody J, Massague J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 1997; 11:984-995. (Biology). 查看参考
  7. Whitman M. Smads and early developmental signaling by the TGFbeta superfamily. Genes Dev. 1998; 12(16):2445-2462. (Biology). 查看参考
  8. Yang J, Davies RJ, Southwood M, et al. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Circ Res. 2008; 102(10):1212-1221. (Biology). 查看参考
查看所有文件 (8) 查看更少内容
562509 Rev. 1

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.